Search research articles
Contact Us
Filters
Showing results (251-260 of 267) with videos related to
Page
of 27
Sort By:
Cancer Chemotherapy and Pharmacology
|
July 18, 2018
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik, Michael Gordon, Frank Tsai, et al.
Cancer Chemotherapy and Pharmacology
|
June 22, 2018
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik, Michael Gordon, Frank Tsai, et al.
Molecular Cancer Research : MCR
|
April 21, 2012
Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes
Melinda D Willard, Mary E Lajiness, Isabella H Wulur, et al.
L'Encephale
|
April 23, 2020
[Suicidal risk prevention in schizophrenia: Importance of family psychoeducation]
Y Hodé, J Dubreucq, E Valladier, et al.
Plos One
|
March 26, 2009
Regulator of G-protein signaling 14 (RGS14) is a selective H-Ras effector
Francis S Willard, Melinda D Willard, Adam J Kimple, et al.
Journal of Veterinary Internal Medicine
|
July 22, 2008
Effect of sample quality on the sensitivity of endoscopic biopsy for detecting gastric and duodenal lesions in dogs and cats
M D Willard, J Mansell, G T Fosgate, et al.
The Journal of Biological Chemistry
|
November 6, 2008
A point mutation to Galphai selectively blocks GoLoco motif binding: direct evidence for Galpha.GoLoco complexes in mitotic spindle dynamics
Francis S Willard, Zhen Zheng, Juan Guo, et al.
Journal of Neuroimmunology
|
February 1, 1997
Structural features and biochemical properties of TNF-alpha converting enzyme (TACE)
M L Moss, S L Jin, J D Becherer, et al.
Journal of Veterinary Internal Medicine
|
December 17, 2009
Effect of tissue processing on assessment of endoscopic intestinal biopsies in dogs and cats
M D Willard, G E Moore, B D Denton, et al.
Molecular Cancer Therapeutics
|
October 25, 2019
A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer
Ryan J Sullivan, Antoine Hollebecque, Keith T Flaherty, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 267) with videos related to
Sort By:
Page
of 27
Cancer Chemotherapy and Pharmacology
|
July 18, 2018
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik, Michael Gordon, Frank Tsai, et al.
Cancer Chemotherapy and Pharmacology
|
June 22, 2018
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik, Michael Gordon, Frank Tsai, et al.
Molecular Cancer Research : MCR
|
April 21, 2012
Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes
Melinda D Willard, Mary E Lajiness, Isabella H Wulur, et al.
L'Encephale
|
April 23, 2020
[Suicidal risk prevention in schizophrenia: Importance of family psychoeducation]
Y Hodé, J Dubreucq, E Valladier, et al.
Plos One
|
March 26, 2009
Regulator of G-protein signaling 14 (RGS14) is a selective H-Ras effector
Francis S Willard, Melinda D Willard, Adam J Kimple, et al.
Journal of Veterinary Internal Medicine
|
July 22, 2008
Effect of sample quality on the sensitivity of endoscopic biopsy for detecting gastric and duodenal lesions in dogs and cats
M D Willard, J Mansell, G T Fosgate, et al.
The Journal of Biological Chemistry
|
November 6, 2008
A point mutation to Galphai selectively blocks GoLoco motif binding: direct evidence for Galpha.GoLoco complexes in mitotic spindle dynamics
Francis S Willard, Zhen Zheng, Juan Guo, et al.
Journal of Neuroimmunology
|
February 1, 1997
Structural features and biochemical properties of TNF-alpha converting enzyme (TACE)
M L Moss, S L Jin, J D Becherer, et al.
Journal of Veterinary Internal Medicine
|
December 17, 2009
Effect of tissue processing on assessment of endoscopic intestinal biopsies in dogs and cats
M D Willard, G E Moore, B D Denton, et al.
Molecular Cancer Therapeutics
|
October 25, 2019
A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer
Ryan J Sullivan, Antoine Hollebecque, Keith T Flaherty, et al.
Page
of 27